Increased risk of second cancers following breast cancer: role of the initial treatment.

PubWeight™: 1.09‹?› | Rank: Top 10%

🔗 View Article (PMID 10965995)

Published in Breast Cancer Res Treat on June 01, 2000

Authors

C Rubino1, F de Vathaire, I Diallo, A Shamsaldin, M G Lê

Author Affiliations

1: Unité de Recherche en Epidemiologie des Cancers de l'Institut National de la Santé et de la Recherche Médicale (U521), Institut Gustave Roussy, Villejuif, France.

Articles citing this

Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries. Lancet Oncol (2011) 2.16

Radiation dose, chemotherapy, hormonal treatment and risk of second cancer after breast cancer treatment. Br J Cancer (2003) 1.29

Second malignancies after breast cancer: the impact of different treatment modalities. Br J Cancer (2008) 1.13

Breast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations. Perm J (2015) 0.98

BRCA1, BRCA2, TP53, and CDKN2A germline mutations in patients with breast cancer and cutaneous melanoma. Fam Cancer (2007) 0.84

The Breast-Thyroid Cancer Link: A Systematic Review and Meta-analysis. Cancer Epidemiol Biomarkers Prev (2016) 0.84

Association between melanocytic nevi and risk of breast diseases: The French E3N prospective cohort. PLoS Med (2014) 0.82

Time trend of multiple myeloma and associated secondary primary malignancies in Asian patients: a Taiwan population-based study. PLoS One (2013) 0.82

Increased risks of third primary cancers of non-breast origin among women with bilateral breast cancer. Br J Cancer (2012) 0.82

Other primary malignancies in breast cancer patients treated with breast conserving surgery and radiation therapy. Ann Surg Oncol (2012) 0.81

Breast cancer survival among young women: a review of the role of modifiable lifestyle factors. Cancer Causes Control (2016) 0.77

Prognostic factors of second primary contralateral breast cancer in early-stage breast cancer. Oncol Lett (2014) 0.77

Risk of second cancer after initial treatment of breast cancer: An Osaka Cancer Registry Database study. Oncol Lett (2011) 0.76

Risk of Second Primary Malignancy in Breast Cancer Survivors: A Nested Population-Based Case-Control Study. J Breast Cancer (2015) 0.75

Risk of secondary cancers in women with breast cancer and the influence of radiotherapy: A national cohort study in Taiwan. Medicine (Baltimore) (2016) 0.75

Two cancers in one: breast carcinoma with underlying melanoma. Proc (Bayl Univ Med Cent) (2017) 0.75

Articles by these authors

Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83

Evidence of behaviour change following a hygiene promotion programme in Burkina Faso. Bull World Health Organ (2001) 2.47

Late local recurrences in a randomised trial comparing conservative treatment with total mastectomy in early breast cancer patients. Ann Oncol (2003) 2.42

Structured observations of hygiene behaviours in Burkina Faso: validity, variability, and utility. Bull World Health Organ (1993) 2.19

Second primary malignancies in thyroid cancer patients. Br J Cancer (2003) 2.10

Breast-conserving therapy vs mastectomy in early-stage breast cancer: a meta-analysis of 10-year survival. Cancer J Sci Am (1997) 2.09

Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. Institut Gustave-Roussy Breast Cancer Group. J Clin Oncol (1996) 2.08

Potties, pits and pipes: explaining hygiene behaviour in Burkina Faso. Soc Sci Med (1995) 1.95

Confirmatory platelet-activating factor receptor antagonist trial in patients with severe gram-negative bacterial sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. BN 52021 Sepsis Investigator Group. Crit Care Med (1998) 1.94

Radiation and genetic factors in the risk of second malignant neoplasms after a first cancer in childhood. Lancet (1997) 1.84

Long-term risk of sarcoma following radiation treatment for breast cancer. Int J Radiat Oncol Biol Phys (1991) 1.77

Analysis of local-regional relapses in patients with early breast cancers treated by excision and radiotherapy: experience of the Institut Gustave-Roussy. Int J Radiat Oncol Biol Phys (1985) 1.74

Breast cancer: relationship between the size of the primary tumour and the probability of metastatic dissemination. Br J Cancer (1984) 1.71

Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer. Radiother Oncol (1989) 1.60

Can internal mammary chain treatment decrease the risk of death for patients with medial breast cancers and positive axillary lymph nodes? Cancer (1990) 1.55

Randomized trial of adjuvant ovarian suppression in 926 premenopausal patients with early breast cancer treated with adjuvant chemotherapy. Ann Oncol (2005) 1.54

Risk factors for failure of immediate breast reconstruction with prosthesis after total mastectomy for breast cancer. Cancer (1992) 1.46

Evidence of increased chromosomal abnormalities in French Polynesian thyroid cancer patients. Eur J Nucl Med Mol Imaging (2004) 1.39

Possible cohort effects in studies on oral contraceptive use and breast cancer. Br J Cancer (1985) 1.38

Radiation dose, chemotherapy and risk of osteosarcoma after solid tumours during childhood. Int J Cancer (1998) 1.32

Leukaemia mortality in French communes (administrative units) with a large and rapid population increase. Br J Cancer (1994) 1.29

Radiation dose, chemotherapy, hormonal treatment and risk of second cancer after breast cancer treatment. Br J Cancer (2003) 1.29

Cardiac abnormalities 15 years and more after adriamycin therapy in 229 childhood survivors of a solid tumour at the Institut Gustave Roussy. Br J Cancer (2004) 1.29

Reactivity and repeatability of hygiene behaviour: structured observations from Burkina Faso. Soc Sci Med (1996) 1.29

[Could treatments with beta-blockers be associated with a reduction in cancer risk?]. Rev Epidemiol Sante Publique (2004) 1.19

Risks of brain tumour following treatment for cancer in childhood: modification by genetic factors, radiotherapy and chemotherapy. Int J Cancer (1998) 1.17

Is it useful to remove internal mammary nodes in operable breast cancer? Eur J Surg Oncol (1987) 1.15

Dirt and diarrhoea: formative research in hygiene promotion programmes. Health Policy Plan (1997) 1.14

Risk factors for breast cancer according to age at diagnosis in a French case-control study. J Clin Epidemiol (1990) 1.14

Thyroid carcinomas after irradiation for a first cancer during childhood. Arch Intern Med (2000) 1.13

Estimation of the radiation dose delivered to any point outside the target volume per patient treated with external beam radiotherapy. Radiother Oncol (1996) 1.12

C-myc proto-oncogene expression and prognosis in early carcinoma of the uterine cervix. Lancet (1987) 1.08

Diet, living conditions and nasopharyngeal carcinoma in Tunisia--a case-control study. Int J Cancer (1990) 1.06

Second malignant neoplasms after a first cancer in childhood: temporal pattern of risk according to type of treatment. Br J Cancer (1999) 1.04

Diabetes and impaired fasting glucose in rural and urban populations in Futa Jallon (Guinea): prevalence and associated risk factors. Diabetes Metab (2007) 1.02

Characterization and radiosensitivity at high or low dose rate of four cell lines derived from human thyroid tumors. Int J Radiat Oncol Biol Phys (1997) 1.02

[Prevalence of the use of skin bleaching cosmetics in two areas in Dakar (Sénégal)]. Dakar Med (2000) 1.02

Variation in the interaction between familial and reproductive factors on the risk of breast cancer according to age, menopausal status, and degree of familiality. Int J Epidemiol (2000) 1.01

Poor prognosis of p53 gene mutation and nuclear overexpression of p53 protein in inflammatory breast carcinoma. J Natl Cancer Inst (1993) 1.01

Relation of risk of contralateral breast cancer to the interval since the first primary tumour. Br J Cancer (2009) 1.00

Successful contracting of prevention services: fighting malnutrition in Senegal and Madagascar. Health Policy Plan (1999) 1.00

Consumption of dairy produce and alcohol in a case-control study of breast cancer. J Natl Cancer Inst (1986) 1.00

c-erbB-2 (HER-2/neu) gene amplification is a better indicator of poor prognosis than protein over-expression in operable breast-cancer patients. Int J Cancer (2001) 0.98

Prolonged breast-feeding: no association with increased risk of clinical malnutrition in young children in Burkina Faso. Bull World Health Organ (1993) 0.96

Long-term effect of internal mammary chain treatment. Results of a multivariate analysis of 1195 patients with operable breast cancer and positive axillary nodes. Radiother Oncol (1988) 0.96

Alcoholic beverage consumption and breast cancer in a French case-control study. Am J Epidemiol (1984) 0.94

Undifferentiated carcinoma of nasopharyngeal type of tonsil. Arch Otolaryngol Head Neck Surg (1989) 0.93

Variations in the risk of breast cancer associated with a family history of breast cancer according to age at onset and reproductive factors. J Clin Epidemiol (1993) 0.92

Longitudinal evaluation of three azithromycin distribution strategies for treatment of trachoma in a sub-Saharan African country, Mali. Acta Trop (2006) 0.92

Combined hormone replacement therapy and risk of breast cancer in a French cohort study of 3175 women. Climacteric (2002) 0.92

Child defecation behaviour, stool disposal practices, and childhood diarrhoea in Burkina Faso: results from a case-control study. J Epidemiol Community Health (1994) 0.91

Predictive factors for local recurrence in 2006 patients with surgically resected small breast cancer. Ann Oncol (2002) 0.89

Dose distribution throughout the body from radiotherapy for Hodgkin's disease in childhood. Radiother Oncol (1998) 0.89

Can breast reconstruction with gel-filled silicone implants increase the risk of death and second primary cancer in patients treated by mastectomy for breast cancer? Plast Reconstr Surg (1994) 0.89

Cancer registry of French Polynesia: results for the 1990-1995 period among native and immigrant population. Eur J Epidemiol (2000) 0.88

[Haematological parameters evolution during the antiretroviral therapy of HIV infected patients in Burkina-Faso]. Bull Soc Pathol Exot (2007) 0.88

MtDNA of Fulani nomads and their genetic relationships to neighboring sedentary populations. Hum Biol (2006) 0.86

Human papillomavirus-negative status and c-myc gene overexpression: independent prognostic indicators of distant metastasis for early-stage invasive cervical cancers. J Natl Cancer Inst (1992) 0.86

Irradiation and second cancers. The thyroid as a case in point. C R Acad Sci III (1999) 0.86

Radiation dose as a risk factor for malignant melanoma following childhood cancer. Eur J Cancer (2003) 0.86

Association of c-erbB2-gene amplification with poor prognosis in non-inflammatory breast carcinomas but not in carcinomas of the inflammatory type. Int J Cancer (1994) 0.85

[In vitro evaluation of the sensitivity of Plasmodium falciparum to chloroquine using the deli-microtest in region of Dakar, Senegal]. Med Trop (Mars) (2005) 0.84

Cancer incidence in French Polynesia 1985-95. Trop Med Int Health (2000) 0.83

Heterogeneity and penetration of HIV-1 non-subtype B viruses in an Italian province: public health implications. Epidemiol Infect (2010) 0.83

[Hypertension: epidemiology and metabolic abnormalities in Foutah-Djallon in Guinea]. Mali Med (2006) 0.81

Estimation of the radiation dose from radiotherapy for skin haemangiomas in childhood: the ICTA software for epidemiology. Phys Med Biol (2000) 0.81

Irradiated neuroblastoma in childhood as potential risk factor for subsequent thyroid tumour. Lancet (1988) 0.80

[Clinical value of C-reactive protein, alpha 1-glycoprotein acid and transferrin assay in homozygous sickle cell disease]. Bull Soc Pathol Exot (1993) 0.80

[Serological and allergological survey of cattle in Niger]. Rev Elev Med Vet Pays Trop (1991) 0.80

Solid malignant neoplasms after childhood irradiation: decrease of the relative risk with time after irradiation. C R Acad Sci III (1995) 0.80

Progestogen use and decreased risk of breast cancer in a cohort study of premenopausal women with benign breast disease. Br J Cancer (1994) 0.80

[Characteristics of the patients "lost to follow-up" and determining factors of loss to follow-up to patients living with HIV at Ouagadougou, Burkina Faso]. Bull Soc Pathol Exot (2015) 0.80

Individual radiation therapy patient whole-body phantoms for peripheral dose evaluations: method and specific software. Phys Med Biol (2009) 0.80

Latency and time-dependent exposure in a case-control study. J Clin Epidemiol (1991) 0.80

[Serological survey on Newcastle and Gumboro diseases, pasteurellosis and pullorosis in local hens in Niger]. Rev Elev Med Vet Pays Trop (1990) 0.79

A probable outbreak of rabies in a group of camels in Niger. Vet Microbiol (1995) 0.79

Coffee consumption, benign breast disease, and breast cancer. Am J Epidemiol (1985) 0.79

Familial risk, abortion and their interactive effect on the risk of breast cancer--a combined analysis of six case-control studies. Br J Cancer (1995) 0.79

Incidence of haematological malignancies in French Polynesia between 1990 and 1995. Leuk Res (1999) 0.78

Effect of a plaster containing DHEP and heparin in acute ankle sprains with oedema: a randomized, double-blind, placebo-controlled, clinical study. Curr Med Res Opin (2010) 0.78

Thyroid volume measurement in external beam radiotherapy patients using CT imaging: correlation with clinical and anthropometric characteristics. Phys Med Biol (2010) 0.78

[Acute respiratory infections in pediatric hospital at Bobo-Dioulasso (Burkina Faso)]. Arch Pediatr (1994) 0.78

OECI Workshop on late side-effects of cancer treatments. Eur J Cancer (2008) 0.78

Individualized phantom based on CT slices and auxological data (ICTA) for dose estimations following radiotherapy for skin haemangioma in childhood. Radiother Oncol (1998) 0.78

Neoadjuvant chemotherapy consisting of cisplatin and continuous infusions of bleomycin and 5-fluorouracil for advanced head and neck cancer. The need for a new stratification for stage IV (M0) disease. Cancer (1991) 0.78